Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03711708Phase 4Completed
Phase 4, randomised, open-label trial of sertraline in major depressive disorder (MDD), obsessive compulsive disorder (OCD), panic disorder and 3 more (2 arms), sponsored by Viatris. Primary endpoints: Area under the sertraline plasma concentration-time curve from time zero to last time point and Maximum observed plasma concentration of sertraline. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03711708.